Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Pharm Gp LSE:OXP London Ordinary Share GB00B3LXPB43 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.50p 1.40p 1.60p 1.50p 1.50p 1.50p 0 07:46:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.8 -1.9 -0.1 - 18.08

Oxford Pharm Gp Share Discussion Threads

Showing 801 to 823 of 825 messages
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
11/9/2017
23:34
Now we have sellers. Any ideas?
carbon man
22/8/2017
18:16
Do not be misled, All trades are shown on ADVFN today are BUYS not sales. This is ready to spike.
carbon man
10/8/2017
18:14
Been watching this stock for months, with their cash balances, it looks like a bounce is due. Any ideas?
carbon man
18/7/2017
09:23
Had to pay a premium at 1.7p... looking for a re-rate.
cantrememberthis2
09/5/2017
13:32
Indeed bp and shareholders should ensure that it is deployed wisely on projects which have a reasonable chance of success, rather then on Marcello's pipe dreams.
timbo003
09/5/2017
11:16
The Company maintains a strong capital base which provides the flexibility to achieve its strategic objectives, with cash balances of GBP 21.5 million as at 30 April 2017. Thats a lot of cash!!!!
barnetpeter
09/5/2017
09:19
Yes indeed PU I hope for his shareholders sake, it's a case of the lemons ripening before the plums.
timbo003
09/5/2017
08:37
timbo003: I supect Woodford has more serious investment loss problems on his plate at the moment - Oxford only 0.37% of portfolio at 31st March so less now.
pugugly
09/5/2017
07:49
This should be the final nail in the coffin for the safer NSAID projects Time for Neil Woodford to act and get rid of Marcello me thinks.
timbo003
19/4/2017
11:54
Well, Ive been buying at these levels and averaging down from previous buys. I'm still convinced something will come good here and with many years of cash in the balance sheet, ongoing sales from the chew thingy (albeit not huge) it's not going to be placing or going out of business for a long time yet.
nick rubens
19/4/2017
11:11
Cash, cash equivalents and short-term investments at 31 December 2016 of GBP21.9m (2015: GBP23.1m), affording flexibility to take selected products through to registration if deemed more likely to create greater shareholder value So now below cash....
barnetpeter
19/4/2017
10:58
bought back in today. Just a few.....never lost on these and nearly halved now since that rns.
barnetpeter
01/4/2017
23:12
Lucky mr risk one shroud dude
barnes4
31/3/2017
14:14
You tell them Barnes Mr Risk1 made 350K on this, he dumped all in the spike
marc antony
31/3/2017
10:39
Why are you sorry Nothing much has changed As long as you don't sell you have lost nowt!!
barnes4
31/3/2017
10:07
thanks from me too timbo kept your research and warnings in mind when I bought the chart and then sold in Feb. Sorry for those still holding today.
toby hall
31/3/2017
09:11
Timbo...right again!! Many on here took their profits from the 1.7 levels and did not hang around....usually because of yr warnings that this was hopeless. This time the price may tank to one pence....
barnetpeter
31/3/2017
09:06
Thank you Timbo. I'll read them with great interest.
greedfear
31/3/2017
08:59
>>>>>>greedfear All they have is a simple mix of ibuprofen and an antacid (think of it as Nurofen plus Malox) If you give them together in the right ratio you reduce the GI effects, but reduce the rate of ibuprofen absorbed (slow onset) and the amount absorbed (ineffective dose) If you change the ratio so there is only a slight reduction in rate of absorption and a slight decrease in the amount absorbed you lose any GI benefits I have posted on this numerous times over the years, here are some links: https://uk.advfn.com/cmn/fbb/thread.php3?id=25679562&from=652#firstpost https://uk.advfn.com/cmn/fbb/thread.php3?id=25679562&from=645#firstpost https://uk.advfn.com/cmn/fbb/thread.php3?id=25679562&from=635#firstpost https://uk.advfn.com/cmn/fbb/thread.php3?id=25679562&from=622#firstpost
timbo003
31/3/2017
08:50
"Alternatively, the FDA has suggested the Company could pursue a claim of reduced GI symptoms only, without requiring such a clinical outcomes study" I wonder if it would not be sufficient to claim 'reduced GI symptoms'. It's known Ibuprofen causes/increases GI problems and that's a big problem. If I were a doctor, just to be on the safe side and better for the patient, I would prescripe the one that has proven to reduce GI symptoms.
greedfear
31/3/2017
08:45
Have to say Timbo, you called this right, yet to my chagrin I am still a holder.
typhoon
31/3/2017
08:40
Why is the technology totally flawed in your opinion?
greedfear
31/3/2017
07:32
A very predictable outcome from the FDA pre-IND meeting Rx use. Why does anyone invests in this company? It is okay saying the cash is equal to the market cap if they are likely to do some thing productive with the cash other than waste it on pipe-dreams, but it is quite evident they are not. The technology (if you can call it that) if totally flawed. I now look forward to the fairly predictable feedback from the pre-IND OTC proposal. As an aside, I see that shares are being offered in the IPO (reverse takeover) of another one of Nigel Theobald's Pipedreams: N4 pharma. That's another one to put into the barge-pole bin. http://www.investegate.co.uk/onzima-ventures-plc--onz-/rns/proposed-acquisition--update---change-of-adviser/201701171040083584U/
timbo003
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170921 08:53:33